ROS and ROS-Mediated Cellular Signaling

Oxidative Medicine and Cellular Longevity

Volumn 2016, Issue , 2016, Pages

  Zhang, Jixiang ^a   Wang, Xiaoli ^a   Vikash, Vikash ^a   Ye, Qing ^a   Wu, Dandan ^a   Liu, Yulan ^a   Dong, Weiguo ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ION EXCHANGE; PROTEINS; SIGNALING;

ASSOCIATED SIGNALING; MECHANISM OF ACTION; MEDIATED CELLULAR SIGNALING; NEURODEGENERATION; PATHOLOGICAL PROCESS; REACTIVE OXYGEN SPECIES; SIGNALING PATHWAYS; SIGNALING PROTEINS;

CELL SIGNALING;

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ADENINE NUCLEOTIDE TRANSLOCASE; CALCIUM; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ION CHANNEL; KELCH LIKE ECH ASSOCIATED PROTEIN 1; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEASOME; PROTEIN KINASE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR NRF2; VOLTAGE DEPENDENT ANION CHANNEL;

HOMEOSTASIS; INTRACELLULAR SIGNALING; REVIEW; SIGNAL TRANSDUCTION; UBIQUITINATION; ANIMAL; ANTIOXIDANT RESPONSIVE ELEMENT; DRUG EFFECTS; HUMAN; METABOLISM; PHYSIOLOGY;

ANIMALS; ANTIOXIDANT RESPONSE ELEMENTS; HOMEOSTASIS; HUMANS; KELCH-LIKE ECH-ASSOCIATED PROTEIN 1; MAP KINASE SIGNALING SYSTEM; NF-E2-RELATED FACTOR 2; NF-KAPPA B; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84960977855     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2016/4350965     Document Type: Review

References (179)

1. H. Zhang, A. M. Gomez, X. Wang, Y. Yan, M. Zheng, and H. Cheng, "ROS regulation of microdomain Ca2+ signalling at the dyads, " Cardiovascular Research, vol. 98, no. 2, pp. 248-258, 2013.
2. L. A. Sena and N. S. Chandel, "Physiological roles of mitochondrial reactive oxygen species, " Molecular Cell, vol. 48, no. 2, pp. 158-166, 2012.
3. M. Giorgio, M. Trinei, E. Migliaccio, and P. G. Pelicci, "Hydrogen peroxide: a metabolic by-product or a common mediator of ageing signals" Nature Reviews Molecular Cell Biology, vol. 8, no. 9, pp. 722-728, 2007.
4. S. I. Liochev, "Reactive oxygen species and the free radical theory of aging, " Free Radical Biology and Medicine, vol. 60, pp. 1-4, 2013.
5. S. G. Rhee, "Cell signaling. H2O2, a necessary evil for cell signaling, " Science, vol. 312, no. 5782, pp. 1882-1883, 2006.
6. Y. S. Bae, H. Oh, S. G. Rhee, and Y. D. Yoo, "Regulation of reactive oxygen species generation in cell signaling, " Molecules and Cells, vol. 32, no. 6, pp. 491-509, 2011.
7. A. A. Alfadda and R. M. Sallam, "Reactive oxygen species in health and disease, " Journal of Biomedicine and Biotechnology, vol. 2012, Article ID936486, 14 pages, 2012.
8. A. Matsuzawa and H. Ichijo, "Stress-responsive protein kinases in redox-regulated apoptosis signaling, "Antioxidants and Redox Signaling, vol. 7, no. 3-4, pp. 472-481, 2005.
9. W. Dröge, "Free radicals in the physiological control of cell function, " Physiological Reviews, vol. 82, no. 1, pp. 47-95, 2002.
10. T. Finkel, "Signal transduction by reactive oxygen species, " Journal of Cell Biology, vol. 194, no. 1, pp. 7-15, 2011.
11. V. G. Grivennikova and A. D. Vinogradov, "Mitochondrial production of reactive oxygen species, " Biochemistry, vol. 78, no. 13, pp. 1490-1511, 2013.
12. A. A. Starkov, "The role of mitochondria in reactive oxygen species metabolism and signaling, " Annals of the New York Academy of Sciences, vol. 1147, pp. 37-52, 2008.
13. L. Galluzzi, E. Morselli, O. Kepp et al., "Mitochondrial gateways to cancer, "Molecular Aspects ofMedicine, vol. 31, no. 1, pp. 1-20, 2010.
14. Q. Chen, E. J. Vazquez, S. Moghaddas, C. L. Hoppel, and E. J. Lesnefsky, "Production of reactive oxygen species by mitochondria: central role of complex III, " The Journal of Biological Chemistry, vol. 278, no. 38, pp. 36027-36031, 2003.
15. D. G. Nicholls and S. L. Budd, "Mitochondria and neuronal survival, " Physiological Reviews, vol. 80, no. 1, pp. 315-360, 2000.
16. J. F. Turrens, "Mitochondrial formation of reactive oxygen species, " The Journal of Physiology, vol. 552, part 2, pp. 335-344, 2003.
17. D. I. Brown and K. K. Griendling, "Nox proteins in signal transduction, " Free Radical Biology and Medicine, vol. 47, no. 9, pp. 1239-1253, 2009.
18. I. P. Harrison and S. Selemidis, "Understanding the biology of reactive oxygen species and their link to cancer: NADPH oxidases as novel pharmacological targets, " Clinical and Experimental Pharmacology and Physiology, vol. 41, no. 8, pp. 533-542, 2014.
19. J. D. Lambeth, "NOX enzymes and the biology of reactive oxygen, " Nature Reviews Immunology, vol. 4, no. 3, pp. 181-189, 2004.
20. M. D. Brand, "The sites and topology ofmitochondrial superoxide production, " Experimental Gerontology, vol. 45, no. 7-8, pp. 466-472, 2010.
21. S. Roberge, J. Roussel, D. C. Andersson et al., "TNF-mediated caspase-8 activation induces ROS production and TRPM2 activation in adult ventricular myocytes, " Cardiovascular Research, vol. 103, no. 1, pp. 90-99, 2014.
22. D. V. Ilatovskaya, T. S. Pavlov, V. Levchenko, and A. Staruschenko, "ROS production as a common mechanism of ENaC regulation by EGF, insulin, and IGF-1, " The American Journal of Physiology-Cell Physiology, vol. 304, no. 1, pp. C102-C111, 2013.
23. M. Clauzure, A. G. Valdivieso, M. M. Massip Copiz, G. Schulman, M. L. Teiber, and T. A. Santa-Coloma, "Disruption of interleukin-1 autocrine signaling rescues complex I activity and improves ROS levels in immortalized epithelial cells with impaired cystic fibrosis transmembrane conductance regulator (CFTR) function, " PLoS ONE, vol. 9, no. 6, Article ID e99257, 2014.
24. M. Large, S. Reichert, S. Hehlgans, C. Fournier, C. Rödel, and F. Rödel, "A non-linear detection of phospho-histone H2AX in EA. hy926 endothelial cells following low-dose X-irradiation is modulated by reactive oxygen species, " Radiation Oncology, vol. 9, article 80, 2014.
25. A.-F. Miller, "Superoxide dismutases: ancient enzymes and new insights, " FEBS Letters, vol. 586, no. 5, pp. 585-595, 2012.
26. M. Marí, A. Morales, A. Colell, C. García-Ruiz, and J. C. Fernández-Checa, "Mitochondrial glutathione, a key survival antioxidant, " Antioxidants and Redox Signaling, vol. 11, no. 11, pp. 2685-2700, 2009.
27. R. Kanwal, M. Pandey, N. Bhaskaran et al., "Protection against oxidative DNA damage and stress in human prostate by glutathione S-transferase P1, "Molecular Carcinogenesis, vol. 53, no. 1, pp. 8-18, 2014.
28. G. Meloni and M. Va?sák, "Redox activity of synuclein-Cu is silenced by Zn7-metallothionein-3, " Free Radical Biology and Medicine, vol. 50, no. 11, pp. 1471-1479, 2011.
29. J. Chen, M. Adikari, R. Pallai, H. K. Parekh, and H. Simpkins, "Dihydrodiol dehydrogenases regulate the generation of reactive oxygen species and the development of cisplatin resistance in human ovarian carcinoma cells, " Cancer Chemotherapy and Pharmacology, vol. 61, no. 6, pp. 979-987, 2008.
30. G. Bonizzi and M. Karin, "The two NF-B activation pathways and their role in innate and adaptive immunity, " Trends in Immunology, vol. 25, no. 6, pp. 280-288, 2004.
31. A. S. Baldwin, "Regulation of cell death and autophagy by IKK and NF-B: critical mechanisms in immune function and cancer, " Immunological Reviews, vol. 246, no. 1, pp. 327-345, 2012.
32. A. Devin, A. Cook, Y. Lin, Y. Rodriguez, M. Kelliher, and Z.-G. Liu, "The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation, " Immunity, vol. 12, no. 4, pp. 419-429, 2000.
33. G. Gloire and J. Piette, "Redox regulation of nuclear posttranslational modifications during NF-B activation, " Antioxidants and Redox Signaling, vol. 11, no. 9, pp. 2209-2222, 2009.
34. S. Basak and A. Hoffmann, "Crosstalk via the NF-B signaling system, " Cytokine and Growth Factor Reviews, vol. 19, no. 3-4, pp. 187-197, 2008.
35. S. Gardam and R. Brink, "Non-canonical NF-B signaling initiated by BAFF influences B cell biology at multiple junctures, " Frontiers in Immunology, vol. 4, article 509, 2014.
36. J. Bauer, S. Namineni, F. Reisinger, J. Zöller, D. Yuan, and M. Heikenwälder, "Lymphotoxin, NF-B, and cancer: the dark side of cytokines, " Digestive Diseases, vol. 30, no. 5, pp. 453-468, 2012.
37. T. Elmetwali, L. S. Young, and D. H. Palmer, "Fas-associated factor (Faf1) is a novel CD40 interactor that regulates CD40-induced NF-B activation via a negative feedback loop, " Cell Death and Disease, vol. 5, no. 5, Article ID e1213, 2014.
38. P. Ramakrishnan, W. Wang, and D. Wallach, "Receptor-specific signaling for both the alternative and the canonical NF-B activation pathways by NF-B-inducing kinase, " Immunity, vol. 21, no. 4, pp. 477-489, 2004.
39. C. Journo, A. Bonnet, A. Favre-bonvin et al., "Human T cell leukemia virus type 2 tax-mediated NF-B activation involves a mechanism independent of tax conjugation to ubiquitin and SUMO, " Journal of Virology, vol. 87, no. 2, pp. 1123-1136, 2013.
40. Y.-J. Song and M.-S. Kang, "Roles of TRAF2 and TRAF3 in Epstein-Barr virus latent membrane protein 1-induced alternative NF-B activation, " Virus Genes, vol. 41, no. 2, pp. 174-180, 2010.
41. S. Schoonbroodt, V. Ferreira, M. Best-Belpomme et al., "Crucial role of the amino-terminal tyrosine residue 42 and the carboxylterminal PEST domain of IB in NF-B activation by an oxidative stress, " Journal of Immunology, vol. 164, no. 8, pp. 4292-4300, 2000.
42. Y. Takada, A. Mukhopadhyay, G. C. Kundu, G. H. Mahabeleshwar, S. Singh, and B. B. Aggarwal, "Hydrogen peroxide activates NF-B through tyrosine phosphorylation of IB and serine phosphorylation of p65. Evidence for the involvement of IB kinase and Syk protein-tyrosine kinase, " The Journal of Biological Chemistry, vol. 278, no. 26, pp. 24233-24241, 2003.
43. N. L. Reynaert, A. van der Vliet, A. S. Guala et al., "Dynamic redox control of NF-B through glutaredoxin-regulated Sglutathionylation of inhibitory B kinase , " Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 35, pp. 13086-13091, 2006.
44. J. V. Cross and D. J. Templeton, "Thiol oxidation of cell signaling proteins: controlling an apoptotic equilibrium, " Journal of Cellular Biochemistry, vol. 93, no. 1, pp. 104-111, 2004.
45. Q. Li and J. F. Engelhardt, "Interleukin-1 induction of NFB is partially regulated by H2O2-mediated activation of NFBinducing kinase, "The Journal of Biological Chemistry, vol. 281, no. 3, pp. 1495-1505, 2006.
46. J.-H. Kim, H.-J. Na, C.-K. Kim et al., "The non-provitamin A carotenoid, lutein, inhibits NF-B-dependent gene expression through redox-based regulation of the phosphatidylinositol 3-kinase/PTEN/Akt and NF-B-inducing kinase pathways: role of H2O2 in NF-B activation, " Free Radical Biology and Medicine, vol. 45, no. 6, pp. 885-896, 2008.
47. M. R. Junttila, S.-P. Li, and J. Westermarck, "Phosphatasemediated crosstalk between MAPK signaling pathways in the regulation of cell survival, " The FASEB Journal, vol. 22, no. 4, pp. 954-965, 2008.
48. T. Ravingerová, M. Baran?cík, and M. Strnisková, "Mitogenactivated protein kinase: a new therapeutic target in cardiac pathology, " Molecular and Cellular Biochemistry, vol. 247, no. 1-2, pp. 127-138, 2003.
49. G. Pimienta and J. Pascual, "Canonical and alternative MAPK signaling, " Cell Cycle, vol. 6, no. 21, pp. 2628-2632, 2007.
50. J. M. Kyriakis and J. Avruch, "Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation, " Physiological Reviews, vol. 81, no. 2, pp. 807-869, 2001.
51. Z. Chen, T. B. Gibson, F. Robinson et al., "MAP kinases, " Chemical Reviews, vol. 101, no. 8, pp. 2449-2476, 2001.
52. W. M. Stadler, "Targeted agents for the treatment of advanced renal cell carcinoma, " Cancer, vol. 104, no. 11, pp. 2323-2333, 2005.
53. E. P. Sproul andW. S. Argraves, "Acytokine axis regulates elastin formation and degradation, " Matrix Biology, vol. 32, no. 2, pp. 86-94, 2013.
54. B. B. Friday and A. A. Adjei, "Advances in targeting the Ras/Raf/MEK/Erk mitogen-activated protein kinase cascade with MEK inhibitors for cancer therapy, " Clinical Cancer Research, vol. 14, no. 2, pp. 342-346, 2008.
55. A. Plotnikov, E. Zehorai, S. Procaccia, and R. Seger, "The MAPK cascades: signaling components, nuclear roles and mechanisms of nuclear translocation, " Biochimica et Biophysica Acta-Molecular Cell Research, vol. 1813, no. 9, pp. 1619-1633, 2011.
56. A. León-Buitimea, L. Rodríguez-Fragoso, F. T. Lauer, H. Bowles, T. A. Thompson, and S. W. Burchiel, "Ethanol-induced oxidative stress is associatedwith EGF receptor phosphorylation inMCF-10A cells overexpressing CYP2E1, " Toxicology Letters, vol. 209, no. 2, pp. 161-165, 2012.
57. H. Lei and A. Kazlauskas, "Growth factors outside of the platelet-derived growth factor (PDGF) family employ reactive oxygen species/Src family kinases to activate PDGF receptor and thereby promote proliferation and survival of cells, " The Journal of Biological Chemistry, vol. 284, no. 10, pp. 6329-6336, 2009.
58. C. C. Wentworth, A. Alam, R. M. Jones, A. Nusrat, and A. S. Neish, "Enteric commensal bacteria induce extracellular signalregulated kinase pathway signaling via formyl peptide receptordependent redox modulation of dual specific phosphatase 3, " The Journal of Biological Chemistry, vol. 286, no. 44, pp. 38448-38455, 2011.
59. A. Banan, J. Z. Fields, Y. Zhang, and A. Keshavarzian, "Phospholipase C- inhibition prevents EGF protection of intestinal cytoskeleton and barrier against oxidants, " The American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 281, no. 2, pp. G412-G423, 2001.
60. R. A. Franklin, P. A. Atherfold, and J. A. McCubrey, "Calciuminduced ERK activation in human T lymphocytes occurs via p56Lck and CaM-kinase, " Molecular Immunology, vol. 37, no. 11, pp. 675-683, 2000.
61. S. G. Dann, J. Golas, M. Miranda et al., "P120 catenin is a key effector of a Ras-PKC oncogenic signaling axis, " Oncogene, vol. 33, no. 11, pp. 1385-1394, 2014.
62. C. Davies and C. Tournier, "Exploring the function of the JNK (c-Jun N-terminal kinase) signalling pathway in physiological and pathological processes to design novel therapeutic strategies, " Biochemical Society Transactions, vol. 40, no. 1, pp. 85-89, 2012.
63. S. S. Leonard, G. K. Harris, and X. Shi, "Metal-induced oxidative stress and signal transduction, " Free Radical Biology and Medicine, vol. 37, no. 12, pp. 1921-1942, 2004.
64. K. Katagiri, A. Matsuzawa, and H. Ichijo, "Regulation of apoptosis signal-regulating kinase 1 in redox signaling, " Methods in Enzymology, vol. 474, pp. 277-288, 2010.
65. M. Castro-Caldas, A. N. Carvalho, E. Rodrigues, C. Henderson, C. R. Wolf, and M. J. Gama, "Glutathione S-transferase pi mediates MPTP-induced c-Jun N-terminal kinase activation in the nigrostriatal pathway, " Molecular Neurobiology, vol. 45, no. 3, pp. 466-477, 2012.
66. J. Matsukawa, A. Matsuzawa, K. Takeda, and H. Ichijo, "The ASK1-MAP kinase cascades inmammalian stress response, "The Journal of Biochemistry, vol. 136, no. 3, pp. 261-265, 2004.
67. B. Grill and J. W. Schrader, "Activation of Rac-1, Rac-2, and Cdc42 by hemopoietic growth factors or cross-linking of the B-lymphocyte receptor for antigen, " Blood, vol. 100, no. 9, pp. 3183-3192, 2002.
68. I. Shin, S. Kim, H. Song, H.-R. C. Kim, and A. Moon, "H-Rasspecific activation of Rac-MKK3/6-p38 pathway: its critical role in invasion and migration of breast epithelial cells, " The Journal of Biological Chemistry, vol. 280, no. 15, pp. 14675-14683, 2005.
69. A. Cuadrado and A. R. Nebreda, "Mechanisms and functions of p38 MAPK signalling, " Biochemical Journal, vol. 429, no. 3, pp. 403-417, 2010.
70. M. Hayashi, C. Fearns, B. Eliceiri, Y. Yang, and J.-D. Lee, "Big mitogen-activated protein kinase 1/extracellular signalregulated kinase 5 signaling pathway is essential for tumorassociated angiogenesis, " Cancer Research, vol. 65, no. 17, pp. 7699-7706, 2005.
71. J. D. Hayes and M. McMahon, "NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer, " Trends in Biochemical Sciences, vol. 34, no. 4, pp. 176-188, 2009.
72. K. Taguchi, H. Motohashi, and M. Yamamoto, "Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution, " Genes to Cells, vol. 16, no. 2, pp. 123-140, 2011.
73. T. W. Kensler, N. Wakabayashi, and S. Biswal, "Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway, " Annual Review of Pharmacology and Toxicology, vol. 47, pp. 89-116, 2007.
74. J.-M. Lee and J. A. Johnson, "An important role of Nrf2-ARE pathway in the cellular defense mechanism, " Journal of Biochemistry and Molecular Biology, vol. 37, no. 2, pp. 139-143, 2004.
75. K.-A. Jung and M.-K. Kwak, "The Nrf2 system as a potential target for the development of indirect antioxidants, " Molecules, vol. 15, no. 10, pp. 7266-7291, 2010.
76. M. Furukawa and Y. Xiong, "BTB protein keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the cullin 3-Roc1 ligase, " Molecular and Cellular Biology, vol. 25, no. 1, pp. 162-171, 2005.
77. N. F. Villeneuve, A. Lau, and D. D. Zhang, "Regulation of the Nrf2-Keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases, " Antioxidants & Redox Signaling, vol. 13, no. 11, pp. 1699-1712, 2010.
78. A. T. Dinkova-Kostova, W. D. Holtzclaw, R. N. Cole et al., "Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants, " Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 18, pp. 11908-11913, 2002.
79. K. C. Kim, K. A. Kang, R. Zhang et al., "Up-regulation of Nrf2-mediated heme oxygenase-1 expression by eckol, a phlorotannin compound, through activation of Erk and PI3K/Akt, " International Journal of Biochemistry and Cell Biology, vol. 42, no. 2, pp. 297-305, 2010.
80. J. W. Kaspar, S. K. Niture, and A. K. Jaiswal, "Nrf2:INrf2 (Keap1) signaling in oxidative stress, " Free Radical Biology andMedicine, vol. 47, no. 9, pp. 1304-1309, 2009.
81. T. Nguyen, P. J. Sherratt, and C. B. Pickett, "Regulatorymechanisms controlling gene expression mediated by the antioxidant response element, " Annual Review of Pharmacology and Toxicology, vol. 43, pp. 233-260, 2003.
82. A. K. Jain and A. K. Jaiswal, "GSK-3 acts upstream of Fyn kinase in regulation of nuclear export and degradation of NFE2 related factor 2, "The Journal of Biological Chemistry, vol. 282, no. 22, pp. 16502-16510, 2007.
83. W. K. Yip and H. F. Seow, "Activation of phosphatidylinositol 3-kinase/Akt signaling by EGF downregulates membranous Ecadherin and catenin and enhances invasion in nasopharyngeal carcinoma cells, " Cancer Letters, vol. 318, no. 2, pp. 162-172, 2012.
84. J. Hong, T. Qian, Q. Le et al., "NGF promotes cell cycle progression by regulating D-type cyclins via PI3K/Akt andMAPK/Erk activation in human corneal epithelial cells, " Molecular Vision, vol. 18, pp. 758-764, 2012.
85. X. Qiu, J.-C. Cheng, H.-M. Chang, and P. C. K. Leung, "COX2 and PGE2 mediate EGF-induced E-cadherin-independent human ovarian cancer cell invasion, " Endocrine-Related Cancer, vol. 21, no. 4, pp. 533-543, 2014.
86. I. E. Ahn, J. H. Ju, S. Y. Lee et al., "Upregulation of stromal cellderived factor by IL-17 and IL-18 via a phosphatidylinositol 3-kinase-dependent pathway, " Scandinavian Journal of Immunology, vol. 76, no. 4, pp. 433-439, 2012.
87. D. A. Cantrell, "Phosphoinositide 3-kinase signalling pathways, " Journal of Cell Science, vol. 114, part 8, pp. 1439-1445, 2001.
88. D. D. Sarbassov, D. A. Guertin, S. M. Ali, and D. M. Sabatini, "Phosphorylation and regulation of Akt/PKB by the rictormTOR complex, " Science, vol. 307, no. 5712, pp. 1098-1101, 2005.
89. P. Cohen and S. Frame, "The renaissance of GSK3, " Nature ReviewsMolecular Cell Biology, vol. 2, no. 10, pp. 769-776, 2001.
90. Y. Zhang, B. Gan, D. Liu, and J.-H. Paik, "FoxO family members in cancer, " Cancer Biology and Therapy, vol. 12, no. 4, pp. 253-259, 2011.
91. X.-S. Zhang, X. Zhang, Q. Wu et al., "Astaxanthin alleviates early brain injury following subarachnoid hemorrhage in rats: possible involvement of Akt/bad signaling, " Marine Drugs, vol. 12, no. 8, pp. 4291-4310, 2014.
92. A. G. Abraham and E. O'Neill, "PI3K/Akt-mediated regulation of p53 in cancer, " Biochemical Society Transactions, vol. 42, no. 4, pp. 798-803, 2014.
93. N. R. Leslie and C. P. Downes, "PTEN: the down side of PI 3-kinase signalling, " Cellular Signalling, vol. 14, no. 4, pp. 285-295, 2002.
94. S.-R. Lee, K.-S. Yang, J. Kwon, C. Lee, W. Jeong, and S. G. Rhee, "Reversible inactivation of the tumor suppressor PTEN by H2O2, " The Journal of Biological Chemistry, vol. 277, no. 23, pp. 20336-20342, 2002.
95. H. Murata, Y. Ihara, H. Nakamura, J. Yodoi, K. Sumikawa, and T. Kondo, "Glutaredoxin exerts an antiapoptotic effect by regulating the redox state of Akt, " The Journal of Biological Chemistry, vol. 278, no. 50, pp. 50226-50233, 2003.
96. A. I. Tarasov, E. J. Griffiths, andG. A. Rutter, "Regulation ofATP production by mitochondrial Ca2+, " Cell Calcium, vol. 52, no. 1, pp. 28-35, 2012.
97. J. R. Naranjo and B. Mellström, "Ca2+-dependent transcriptional control of Ca2+ homeostasis, " The Journal of Biological Chemistry, vol. 287, no. 38, pp. 31674-31680, 2012.
98. M. J. Berridge, M. D. Bootman, and H. L. Roderick, "Calcium signalling: dynamics, homeostasis and remodelling, " Nature Reviews Molecular Cell Biology, vol. 4, no. 7, pp. 517-529, 2003.
99. A. Felsenfeld, M. Rodriguez, and B. Levine, "New insights in regulation of calcium homeostasis, " Current Opinion in Nephrology and Hypertension, vol. 22, no. 4, pp. 371-376, 2013.
100. P. B. Stathopulos andM. Ikura, "Partial unfolding andoligomerization of stromal interaction molecules as an initiation mechanism of store operated calcium entry, " Biochemistry and Cell Biology, vol. 88, no. 2, pp. 175-183, 2010.
101. T. Kurosaki andY. Baba, "Ca2+ signaling and STIM1, " Progress in Biophysics andMolecular Biology, vol. 103, no. 1, pp. 51-58, 2010.
102. M. Mándi and J. Bak, "Nicotinic acid adenine dinucleotide phosphate (NAADP) and Ca2+ mobilization, " Journal of Receptors and Signal Transduction, vol. 28, no. 3, pp. 163-184, 2008.
103. M. Brini, T. Cal, D. Ottolini, and E. Carafoli, "The plasma membrane calcium pump in health and disease, " The FEBS Journal, vol. 280, no. 21, pp. 5385-5397, 2013.
104. K. Samanta, S. Douglas, and A. B. Parekh, "Mitochondrial calcium uniporter MCU supports cytoplasmic Ca2+ oscillations, store-operated Ca2+ entry and Ca2+-dependent gene expression in response to receptor stimulation, " PLoS ONE, vol. 9, no. 7, Article ID e101188, 2014.
105. A. Lewis, T. Hayashi, T.-P. Su, and M. J. Betenbaugh, "Bcl-2 family in inter-organellemodulation of calcium signaling; roles in bioenergetics and cell survival, " Journal of Bioenergetics and Biomembranes, vol. 46, no. 1, pp. 1-15, 2014.
106. A. Hatano, J.-I. Okada, T. Washio, T. Hisada, and S. Sugiura, "Mitochondrial colocalization with Ca2+ release sites is crucial to cardiac metabolism, " Biophysical Journal, vol. 104, no. 2, pp. 496-504, 2013.
107. C. Konràd, G. Kiss, B. Töröcsik et al., "A distinct sequence in the adenine nucleotide translocase from Artemia franciscana embryos is associated with insensitivity to bongkrekate and atypical effects of adenine nucleotides on Ca2+ uptake and sequestration, " The FEBS Journal, vol. 278, no. 5, pp. 822-836, 2011.
108. K. J. Menzies, B. H. Robinson, andD. A. Hood, "Effect of thyroid hormone on mitochondrial properties and oxidative stress in cells from patients with mtDNA defects, " American Journal of Physiology-Cell Physiology, vol. 296, no. 2, pp. C355-C362, 2009.
109. A. C. Montezano, D. Burger, G. S. Ceravolo, H. Yusuf, M. Montero, and R. M. Touyz, "Novel nox homologues in the vasculature: focusing on Nox4 and Nox5, " Clinical Science, vol. 120, no. 4, pp. 131-141, 2011.
110. N. D. Roe, E. Y. He, Z. Wu, and J. Ren, "Folic acid reverses nitric oxide synthase uncoupling and prevents cardiac dysfunction in insulin resistance: role of Ca2+/calmodulin-activated protein kinase II, " Free Radical Biology and Medicine, vol. 65, pp. 234-243, 2013.
111. A. V. Gordeeva, R. A. Zvyagilskaya, and Y. A. Labas, "Crosstalk between reactive oxygen species and calciumin living cells, " Biochemistry, vol. 68, no. 10, pp. 1077-1080, 2003.
112. M. D. Thompson, Y. Mei, R. M. Weisbrod et al., "Glutathione adducts on sarcoplasmic/endoplasmic reticulum Ca2+ ATPase Cys-674 regulate endothelial cell calcium stores and angiogenic function as well as promote ischemic blood flow recovery, " The Journal of Biological Chemistry, vol. 289, no. 29, pp. 19907-19916, 2014.
113. B. An, Y. Chen, B. Li, G. Qin, and S. Tian, "Ca2+-CaM regulating viability of Candida guilliermondii under oxidative stress by acting on detergent resistant membrane proteins, " Journal of Proteomics, vol. 109, pp. 38-49, 2014.
114. R. Chaube, D. T. Hess, Y.-J. Wang et al., "Regulation of the skeletal muscle ryanodine receptor/Ca2+-release channel RyR1 by S-palmitoylation, " The Journal of Biological Chemistry, vol. 289, no. 12, pp. 8612-8619, 2014.
115. I. Bogeski and B. A. Niemeyer, "Redox regulation of ion channels, " Antioxidants and Redox Signaling, vol. 21, no. 6, pp. 859-862, 2014.
116. P. Kaplan, E. Babusikova, J. Lehotsky, and D. Dobrota, "Free radical-induced protein modification and inhibition of Ca2+-ATPase of cardiac sarcoplasmic reticulum, " Molecular and Cellular Biochemistry, vol. 248, no. 1-2, pp. 41-47, 2003.
117. G. H. Lushington, A. Zaidi, and M. L. Michaelis, "Theoretically predicted structures of plasma membrane Ca2+-ATPase and their susceptibilities to oxidation, " Journal ofMolecularGraphics and Modelling, vol. 24, no. 3, pp. 175-185, 2005.
118. M. Nishida, T. Ishikawa, S. Saiki et al., "Voltage-dependent Ntype Ca2+ channels in endothelial cells contribute to oxidative stress-related endothelial dysfunction induced by angiotensin II in mice, " Biochemical and Biophysical Research Communications, vol. 434, no. 2, pp. 210-216, 2013.
119. G. Morciano, C. Giorgi, M. Bonora et al., "Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury, " Journal of Molecular and Cellular Cardiology, vol. 78, pp. 142-153, 2015.
120. V. K. Rao, E. A. Carlson, and S. S. Yan, "Mitochondrial permeability transition pore is a potential drug target for neurodegeneration, " Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, vol. 1842, no. 8, pp. 1267-1272, 2014.
121. G. Basañez, L. Soane, and J. M. Hardwick, "A new view of the lethal apoptotic pore, " PLoS Biology, vol. 10, no. 9, Article ID e1001399, 2012.
122. Y. Liu and X. J. Chen, "Adenine nucleotide translocase, mitochondrial stress, and degenerative cell death, " Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 146860, 10 pages, 2013.
123. K. S. McCommis and C. P. Baines, "The role of VDAC in cell death: friend or foe" Biochimica et Biophysica Acta, vol. 1818, no. 6, pp. 1444-1450, 2012.
124. A. P. Halestrap, E. Doran, J. P. Gillespie, and A. O'Toole, "Mitochondria and cell death, " Biochemical Society Transactions, vol. 28, no. 2, pp. 170-177, 2000.
125. L. Ghibelli and M. Diederich, "Multistep and multitask Bax activation, " Mitochondrion, vol. 10, no. 6, pp. 604-613, 2010.
126. G. Gouspillou, N. Sgarioto, S. Kapchinsky et al., "Increased sensitivity to mitochondrial permeability transition and myonuclear translocation of endonuclease G in atrophied muscle of physically active older humans, " The FASEB Journal, vol. 28, no. 4, pp. 1621-1633, 2014.
127. A. P. Halestrap, S. J. Clarke, and S. A. Javadov, "Mitochondrial permeability transition pore opening during myocardial reperfusion-a target for cardioprotection, " Cardiovascular Research, vol. 61, no. 3, pp. 372-385, 2004.
128. A. P. Halestrap, "What is the mitochondrial permeability transition pore" Journal of Molecular and Cellular Cardiology, vol. 46, no. 6, pp. 821-831, 2009.
129. G. P. McStay, S. J. Clarke, and A. P. Halestrap, "Role of critical thiol groups on the matrix surface of the adenine nucleotide translocase in the mechanism of the mitochondrial permeability transition pore, " Biochemical Journal, vol. 367, no. 2, pp. 541-548, 2002.
130. G. Sánchez, C. Fernández, L. Montecinos, R. J. Domenech, and P. Donoso, "Preconditioning tachycardia decreases the activity of the mitochondrial permeability transition pore in the dog heart, " Biochemical and Biophysical Research Communications, vol. 410, no. 4, pp. 916-921, 2011.
131. P.-T. Brinkkoetter, H. Song, R. Lösel et al., "Hypothermic injury: themitochondrial calcium, ATP and ROS love-hate triangle out of balance, " Cellular Physiology and Biochemistry, vol. 22, no. 1-4, pp. 195-204, 2008.
132. S. Voronina, E. Okeke, T. Parker, and A. Tepikin, "How to win ATP and influence Ca2+ signaling, " Cell Calcium, vol. 55, no. 3, pp. 131-138, 2014.
133. Y. Deng, X. Ren, L. Yang, Y. Lin, and X. Wu, "AJNK-dependent pathway is required for TNFinduced apoptosis, " Cell, vol. 115, no. 1, pp. 61-70, 2003.
134. M. Maryanovich and A. Gross, "A ROS rheostat for cell fate regulation, " Trends in Cell Biology, vol. 23, no. 3, pp. 129-134, 2013.
135. S. Wagner, A. G. Rokita, M. E. Anderson, and L. S. Maier, "Redox regulation of sodium and calcium handling, " Antioxidants and Redox Signaling, vol. 18, no. 9, pp. 1063-1077, 2013.
136. J. W. Thompson, S. V. Narayanan, and M. A. Perez-Pinzon, "Redox signaling pathways involved in neuronal ischemic preconditioning, "CurrentNeuropharmacology, vol. 10, no. 4, pp. 354-369, 2012.
137. A. Eisenberg-Lerner and A. Kimchi, "PKD is a kinase of Vps34 that mediates ROS-induced autophagy downstream of DAPk, " Cell Death and Differentiation, vol. 19, no. 5, pp. 788-797, 2012.
138. J. S. Kruk, M. S. Vasefi, J. J. Heikkila, and M. A. Beazely, "Reactive oxygen species are required for 5-HT-induced transactivation of neuronal platelet-derived growth factor and TrkB receptors, but not for ERK1/2 activation, " PLoS ONE, vol. 8, no. 9, Article ID e77027, 2013.
139. C. M. Sag, H. A. Wolff, K. Neumann et al., "Ionizing radiation regulates cardiac Ca handling via increased ROS and activated CaMKII, " Basic Research in Cardiology, vol. 108, no. 6, article 385, 2013.
140. G. A. Ramirez-Correa, S. Cortassa, B. Stanley, W. D. Gao, and A. M. Murphy, "Calcium sensitivity, force frequency relationship and cardiac troponin I: critical role of PKA and PKC phosphorylation sites, " Journal ofMolecular and Cellular Cardiology, vol. 48, no. 5, pp. 943-953, 2010.
141. S. S. Taylor, P. Zhang, J. M. Steichen, M. M. Keshwani, and A. P. Kornev, "PKA: Lessons learned after twenty years, " Biochimica et Biophysica Acta-Proteins and Proteomics, vol. 1834, no. 7, pp. 1271-1278, 2013.
142. J. P. Brennan, S. C. Bardswell, J. R. Burgoyne et al., "Oxidantinduced activation of type I protein kinase A is mediated by RI subunit interprotein disulfide bond formation, " The Journal of Biological Chemistry, vol. 281, no. 31, pp. 21827-21836, 2006.
143. S. Papa, D. D. Rasmo, Z. Technikova-Dobrova et al., "Respiratory chain complex I, a main regulatory target of the cAMP/PKA pathway is defective in different human diseases, " FEBS Letters, vol. 586, no. 5, pp. 568-577, 2012.
144. S. Papa and D. De Rasmo, "Complex I deficiencies in neurological disorders, " Trends in Molecular Medicine, vol. 19, no. 1, pp. 61-69, 2013.
145. A. do Carmo, J. Balça-Silva, D. Matias, and M. C. Lopes, "PKC signaling in glioblastoma, " Cancer Biology and Therapy, vol. 14, no. 4, pp. 287-294, 2013.
146. I.-T. Lee and C.-M. Yang, "Inflammatory signalings involved in airway and pulmonary diseases, " Mediators of Inflammation, vol. 2013, Article ID791231, 12 pages, 2013.
147. M. Nitti, M. A. Pronzato, U. M. Marinari, and C. Domenicotti, "PKC signaling in oxidative hepatic damage, "Molecular Aspects of Medicine, vol. 29, no. 1-2, pp. 36-42, 2008.
148. D. Mochly-Rosen, K. Das, and K. V. Grimes, "Protein kinase C, an elusive therapeutic target" Nature Reviews Drug Discovery, vol. 11, no. 12, pp. 937-957, 2012.
149. A. Welman, J. R. Griffiths, A. D. Whetton, and C. Dive, "Protein kinase C delta is phosphorylated on five novel Ser/Thr sites following inducible overexpression in human colorectal cancer cells, " Protein Science, vol. 16, no. 12, pp. 2711-2715, 2007.
150. C. Aicart-Ramos, L. Sánchez-Ruiloba, M. Gómez-Parrizas, C. Zaragoza, T. Iglesias, and I. Rodríguez-Crespo, "Protein kinase D activity controls endothelial nitric oxide synthesis, " Journal of Cell Science, vol. 127, part 15, pp. 3360-3372, 2014.
151. L. O. Olala, B. A. Shapiro, T. C. Merchen, J. J. Wynn, and W. B. Bollag, "Protein kinase C and Src family kinases mediate angiotensin II-induced protein kinase D activation and acute aldosterone production, "Molecular and Cellular Endocrinology, vol. 392, no. 1-2, pp. 173-181, 2014.
152. G. Li and Y. Wang, "Protein kinase D: a new player among the signaling proteins that regulate functions in the nervous system, " Neuroscience Bulletin, vol. 30, no. 3, pp. 497-504, 2014.
153. M. A. Olayioye, S. Barisic, and A. Hausser, "Multi-level control of actin dynamics by protein kinase D, " Cellular Signalling, vol. 25, no. 9, pp. 1739-1747, 2013.
154. Q. J. Wang, "PKD at the crossroads of DAG and PKC signaling, " Trends in Pharmacological Sciences, vol. 27, no. 6, pp. 317-323, 2006.
155. C. F. Cowell, H. Döppler, I. K. Yan, A. Hausser, Y. Umazawa, and P. Storz, "Mitochondrial diacylglycerol initiates protein-kinase-D1-mediated ROS signaling, " Journal of Cell Science, vol. 122, no. 7, pp. 919-928, 2009.
156. P. Storz and A. Toker, "Protein kinase D mediates a stressinduced NF-B activation and survival pathway, " The EMBO Journal, vol. 22, no. 1, pp. 109-120, 2003.
157. P. Storz, H. Döppler, and A. Toker, "Activation loop phosphorylation controls protein kinase D-dependent activation of nuclear factor B, " Molecular Pharmacology, vol. 66, no. 4, pp. 870-879, 2004.
158. C. M. Sag, S. Wagner, and L. S. Maier, "Role of oxidants on calciumand sodium movement in healthy and diseased cardiac myocytes, " Free Radical Biology and Medicine, vol. 63, pp. 338-349, 2013.
159. S. Dietrich, R. Uppalapati, T. Y. Seiwert, and P. C. Ma, "Role of c-MET in upper aerodigestive malignancies-from biology to novel therapies, " Journal of Environmental Pathology, Toxicology and Oncology, vol. 24, no. 3, pp. 149-162, 2005.
160. J. Calise and S. R. Powell, "Theubiquitin proteasome system and myocardial ischemia, " The American Journal of Physiology-Heart and Circulatory Physiology, vol. 304, no. 3, pp. H337-H349, 2013.
161. I. A. Voutsadakis, "The ubiquitin-proteasome system and signal transduction pathways regulating Epithelial Mesenchymal transition of cancer, " Journal of Biomedical Science, vol. 19, no. 1, article 67, 2012.
162. M. Isasa, A. Zuin, and B. Crosas, "Integration of multiple ubiquitin signals in proteasome regulation, " Methods in Molecular Biology, vol. 910, pp. 337-370, 2012.
163. M. Kim, R. Otsubo, H. Morikawa et al., "Bacterial effectors and their functions in the ubiquitin-proteasome system: insight from the modes of substrate recognition, " Cells, vol. 3, no. 3, pp. 848-864, 2014.
164. S. R. Powell, J. Herrmann, A. Lerman, C. Patterson, and X. Wang, "The ubiquitin-proteasome system and cardiovascular disease, " Progress inMolecular Biology and Translational Science, vol. 109, pp. 295-346, 2012.
165. K. M. S. E. Reyskens and M. F. Essop, "HIV protease inhibitors and onset of cardiovascular diseases: a central role for oxidative stress and dysregulation of the ubiquitin-proteasome system, " Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, vol. 1842, no. 2, pp. 256-268, 2014.
166. A. Segref, É. Kevei, W. Pokrzywa et al., "Pathogenesis of human mitochondrial diseases is modulated by reduced activity of the ubiquitin/proteasome system, " Cell Metabolism, vol. 19, no. 4, pp. 642-652, 2014.
167. A. Warnatsch, T. Bergann, and E. Krüger, "Oxidation matters: the ubiquitin proteasome system connects innate immune mechanisms withMHC class I antigen presentation, "Molecular Immunology, vol. 55, no. 2, pp. 106-109, 2013.
168. Y.-D. Kwak, B. Wang, J. J. Li et al., "Upregulation of the E3 ligase NEDD4-1 by oxidative stress degrades IGF-1 receptor protein in neurodegeneration, " The Journal of Neuroscience, vol. 32, no. 32, pp. 10971-10981, 2012.
169. M. Obin, F. Shang, X. Gong, G. Handelman, J. Blumberg, and A. Taylor, "Redox regulation of ubiquitin-conjugating enzymes: mechanistic insights using the thiol-specific oxidant diamide, " The FASEB Journal, vol. 12, no. 7, pp. 561-569, 1998.
170. J. Jahngen-Hodge, M. S. Obin, X. Gong et al., "Regulation of ubiquitin-conjugating enzymes by glutathione following oxidative stress, " The Journal of Biological Chemistry, vol. 272, no. 45, pp. 28218-28226, 1997.
171. A. Kumar, H. Wu, L. S. Collier-Hyams et al., "Commensal bacteria modulate cullin-dependent signaling via generation of reactive oxygen species, " The EMBO Journal, vol. 26, no. 21, pp. 4457-4466, 2007.
172. H. Tian, B. Zhang, J. Di et al., "Keap1: one stone kills three birds Nrf2, IKK and Bcl-2/Bcl-xL, " Cancer Letters, vol. 325, no. 1, pp. 26-34, 2012.
173. K. K. S. Nordgren and K. B. Wallace, "Keap1 redox-dependent regulation of doxorubicin-induced oxidative stress response in cardiac myoblasts, " Toxicology and Applied Pharmacology, vol. 274, no. 1, pp. 107-116, 2014.
174. H. Kanzaki, F. Shinohara, M. Kajiya, and T. Kodama, "The Keap1/Nrf2 protein axis plays a role in osteoclast differentiation by regulating intracellular reactive oxygen species signaling, " The Journal of Biological Chemistry, vol. 288, no. 32, pp. 23009-23020, 2013.
175. T. Reinheckel, O. Ullrich, N. Sitte, and T. Grune, "Differential impairment of 20S and 26S proteasome activities in human hematopoietic K562 cells during oxidative stress, " Archives of Biochemistry and Biophysics, vol. 377, no. 1, pp. 65-68, 2000.
176. F. Shang and A. Taylor, "Ubiquitin-proteasome pathway and cellular responses to oxidative stress, " Free Radical Biology and Medicine, vol. 51, no. 1, pp. 5-16, 2011.
177. A. Sickmann, J. Reinders, Y. Wagner et al., "The proteome of Saccharomyces cerevisiae mitochondria, " Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 23, pp. 13207-13212, 2003.
178. H. B. Jeon, E. S. Choi, J. H. Yoonet al., "Aproteomics approach to identify the ubiquitinated proteins inmouse heart, " Biochemical and Biophysical Research Communications, vol. 357, no. 3, pp. 731-736, 2007.
179. J. Peng, D. Schwartz, J. E. Elias et al., "A proteomics approach to understanding protein ubiquitination, " Nature Biotechnology, vol. 21, no. 8, pp. 921-926, 2003.